hdm1002
Small moleculeexperimental
Clinical trial activity
11 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
5
Phase 3
3
Phase 4
0
Earliest trial started Jun 30, 2024 (NCT06481085)
Timeline
Indications
Mechanism of action
GLP1R agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07193459 | Phase 3 | Aug 12, 2025 | Hangzhou Zhongmei |
| NCT07082114 | Phase 3 | Jul 14, 2025 | Hangzhou Zhongmei |
| NCT06885021 | Phase 3 | Mar 28, 2025 | Hangzhou Zhongmei |
| NCT06985615 | Phase 1 | Mar 18, 2025 | Hangzhou Zhongmei |
| NCT06601517 | Phase 1 | Oct 31, 2024 | Hangzhou Zhongmei |
| NCT06608329 | Phase 1 | Oct 31, 2024 | Hangzhou Zhongmei |
| NCT06576401 | Phase 1 | Aug 27, 2024 | Hangzhou Zhongmei |
| NCT06562088 | Phase 1 | Aug 16, 2024 | Hangzhou Zhongmei |
| NCT06520540 | Phase 1 | Jul 28, 2024 | Hangzhou Zhongmei, Xiamen University |
| NCT06500299 | Phase 2 | Jul 15, 2024 | Hangzhou Zhongmei, Xiamen University |
| NCT06481085 | Phase 2 | Jun 30, 2024 | Hangzhou Zhongmei, People's Liberation Army of China |
Showing 11 of 11 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hangzhou Zhongmei | For profit | 11 | 11 | 3 | 2024 |
| Xiamen University | Academic/Hospital | 2 | 0 | 2 | 2024 |
| People's Liberation Army of China | Government | 1 | 0 | 1 | 2024 |
3 organizations
Page 1 / 1